NuCana (NCNA) Other Non-Current Assets (2021 - 2023)
NuCana's (NCNA) quarterly Other Non-Current Assets came in at $3.2 million in Q2 2023, down 0.94% year-on-year from $3.3 million in Q2 2022, and up 0.55% quarter-over-quarter from $3.2 million in Q1 2023.
NuCana (NCNA) Other Non-Current Assets (2021 - 2023) Analysis & Trends
NuCana has disclosed Other Non-Current Assets across 3 years of filings, most recently posting $3.2 million for Q2 2023.
- Other Non-Current Assets for Q2 2023 came in at $3.2 million, down 0.94% year-over-year; the trailing twelve-month figure through Jun 2023 was $3.2 million (down 0.94% YoY), and the FY2022 annual result was $3.3 million, down 4.95% from the prior year.
- Other Non-Current Assets came in at $3.2 million for Q2 2023 at NuCana, up from $3.2 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $3.6 million in Q3 2021 to a low of $3.1 million in Q3 2022.
- The 3-year median for Other Non-Current Assets is $3.3 million (2023), against an average of $3.3 million.
- Across the five-year window, Other Non-Current Assets fell 12.7% in 2022 and dropped 0.94% in 2023, its largest moves.
- NuCana's Other Non-Current Assets stood at $3.4 million in 2021, then retreated by 8.06% to $3.1 million in 2022, then grew by 3.19% to $3.2 million in 2023.
- The last three Other Non-Current Assets figures came in at $3.2 million (Q2 2023), $3.2 million (Q1 2023), and $3.1 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 3.25 Mn |
| Mar 31, 2023 | 3.23 Mn |
| Dec 31, 2022 | 3.15 Mn |
| Sep 30, 2022 | 3.13 Mn |
| Jun 30, 2022 | 3.28 Mn |
| Mar 31, 2022 | 3.43 Mn |
| Dec 31, 2021 | 3.42 Mn |
| Sep 30, 2021 | 3.58 Mn |